D-Index & Metrics Best Publications

Volkmar Müller

Universität Hamburg
Germany

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Medicine D-index 72 Citations 22,913 506 World Ranking 16198 National Ranking 831

Overview

What is he best known for?

The fields of study Volkmar Müller is best known for:

Fluorescence
Quantum mechanics
Fluorescence microscope

His work in Optics is not limited to one particular discipline; it also encompasses Detector. As part of his studies on Detector, he often connects relevant areas like Optics. Quantum mechanics and Dispersion (optics) are frequently intertwined in his study. Dispersion (optics) is closely attributed to Quantum mechanics in his study. His multidisciplinary approach integrates Large Hadron Collider and Particle physics in his work. He integrates Particle physics and Nuclear physics in his studies. Many of his studies on Nuclear physics apply to Large Hadron Collider as well. He performs multidisciplinary study in the fields of Position (finance) and Finance via his papers. Volkmar Müller combines Finance and Position (finance) in his research.

His most cited work include:

STED Nanoscopy Reveals Molecular Details of Cholesterol- and Cytoskeleton-Modulated Lipid Interactions in Living Cells (226 citations)
On the physical origin of dark matter density profiles (121 citations)
Non-Debye dielectric dispersion of barium titanate stannate in the relaxor and diffuse phase-transition state (64 citations)

What are the main themes of his work throughout his whole career to date

Volkmar Müller's looking at Metastasis as part of his Circulating tumor cell and Primary tumor and Metastasis study. His work on Proportional hazards model expands to the thematically related Internal medicine. His research is interdisciplinary, bridging the disciplines of Internal medicine and Proportional hazards model. Volkmar Müller carries out multidisciplinary research, doing studies in Cancer and Chemotherapy. His work blends Chemotherapy and Metastasis studies together. His study deals with a combination of Breast cancer and Metastatic breast cancer. Volkmar Müller combines Oncology and Pathology in his research. In his works, Volkmar Müller conducts interdisciplinary research on Pathology and Oncology. He performs integrative study on Quantum mechanics and Optics.

Volkmar Müller most often published in these fields:

Internal medicine (40.00%)
Cancer (35.00%)
Breast cancer (30.00%)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Tumour exosome integrins determine organotropic metastasis

Ayuko Hoshino;Bruno Costa-Silva;Tang-Long Shen;Goncalo Rodrigues.
Nature (2015)

3433 Citations

Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch System

Sabine Riethdorf;Herbert Fritsche;Volkmar Müller;Thomas Rau.
Clinical Cancer Research (2007)

1435 Citations

A New Molecular Predictor of Distant Recurrence in ER-Positive, HER2-Negative Breast Cancer Adds Independent Information to Conventional Clinical Risk Factors

Martin Filipits;Margaretha Rudas;Raimund Jakesz;Peter Dubsky.
Clinical Cancer Research (2011)

682 Citations

Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer.

Rashmi K Murthy;Sherene Loi;Alicia Okines;Elisavet Paplomata.
The New England Journal of Medicine (2020)

610 Citations

Pathologic Complete Response After Neoadjuvant Chemotherapy Plus Trastuzumab Predicts Favorable Survival in Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer: Results From the TECHNO Trial of the AGO and GBG Study Groups

Michael Untch;Peter A. Fasching;Gottfried E. Konecny;Stephan Hasmüller.
Journal of Clinical Oncology (2011)

589 Citations

Detection and HER2 Expression of Circulating Tumor Cells: Prospective Monitoring in Breast Cancer Patients Treated in the Neoadjuvant GeparQuattro Trial

Sabine Riethdorf;Volkmar Müller;Liling Zhang;Thomas Rau.
Clinical Cancer Research (2010)

537 Citations

Circulating Tumor Cells in Breast Cancer: Correlation to Bone Marrow Micrometastases, Heterogeneous Response to Systemic Therapy and Low Proliferative Activity

Volkmar Müller;Nicole Stahmann;Sabine Riethdorf;Thomas Rau.
Clinical Cancer Research (2005)

492 Citations

Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer

Carina Roth;Brigitte Rack;Volkmar Müller;Wolfgang Janni.
Breast Cancer Research (2010)

486 Citations

HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial

Tanja Fehm;Volkmar Müller;Bahriye Aktas;Wolfgang Janni.
Breast Cancer Research and Treatment (2010)

368 Citations

The carboxy-terminal F domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists.

Monica M. Montano;Volkmar Müller;Angela Trobaugh;Benita S Katzenellenbogen.
Molecular Endocrinology (1995)

368 Citations

If you think any of the details on this page are incorrect, let us know.

Frequent Co-Authors

External Links

Personal Website for Volkmar Müller

Volkmar Müller

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Overview

What is he best known for?